肝移植患者可以避免使用药物超过三年. New immune therapy allows liver transplant patients to avoid drugs for over three years.

美国宾夕法尼亚州立医院和匹兹堡大学的研究人员已经为肝移植患者测试了一种新的免疫疗法. Researchers at UPMC and the University of Pittsburgh have tested a new immune therapy for liver transplant patients. 治疗使用来自捐赠者的细胞来训练免疫系统接受新器官, 而无需长期服用抑制免疫力的药物. The treatment uses donor-derived cells to train the immune system to accept a new organ without long-term immunosuppressant drugs. 在一项小型试验中,四名患者成功停用药物超过三年, 显示了降低损伤和感染等严重副作用的潜力. In a small trial, four patients successfully remained off the drugs for over three years, showing potential to reduce serious side effects like kidney damage and infections.